Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.

NCT02341118 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02341118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Terminated
Start date
May 31, 2014
Completion date
May 8, 2023
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer